[5] [6] However, the absolute risk remained low , and the study's observational design could not definitively establish causation
Even though insulin has been around for 100+ years, the price of insulin continues to increase (see above re: sticky prices)
It is available at virtually every pharmacy in the country, requires no special handling or refrigeration, and prescriptions can often be obtained through telemedicine platforms with minimal friction
GLP-1 receptor agonists (GLP-1RAs) are well established for glycemic control and weight reduction in patients with type 2 diabetes mellitus (T2DM) and/or obesity and have demonstrated cardiovascular benefit [2]
While smaller trials provide insight, definitive guidance is still evolving
A higher subcutaneous dose of semaglutide (7.2 mg weekly)93 is currently under investigation in a Phase III clinical trial